| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/12/2005 | EP1495115A2 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
| 01/12/2005 | EP1495110A1 Recombinant spores |
| 01/12/2005 | EP1495054A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495052A1 Modified factor viii |
| 01/12/2005 | EP1495047A2 Synthetic active peptide fragments |
| 01/12/2005 | EP1495039A2 Neisseria mutants, lipooligosaccharides and immunogenic compositions |
| 01/12/2005 | EP1494752A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 01/12/2005 | EP1494722A1 Treatment methods for eotaxin mediated inflammatory conditions |
| 01/12/2005 | EP1494715A1 Fp receptor antagonists or pgf2 aplha antagonists for treating menorrhagia |
| 01/12/2005 | EP1494714A2 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors |
| 01/12/2005 | EP1494713A2 Methods for treating tweak-related conditions |
| 01/12/2005 | EP1494711A1 Methods for treating chronic obstructive pulmonary disease (copd) |
| 01/12/2005 | EP1494710A2 Diabetes-related immunoglobulin derived proteins, compostions, methods and uses |
| 01/12/2005 | EP1494709A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/12/2005 | EP1494708A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 01/12/2005 | EP1494701A2 Immunosuppressant compounds, methods and uses related thereto |
| 01/12/2005 | EP1494693A2 Cripto-specific antibodies |
| 01/12/2005 | EP1494690A2 Cochleates made with purified soy phosphatidylserine |
| 01/12/2005 | EP1494687A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 01/12/2005 | EP1494665A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 01/12/2005 | EP1494662A1 Tnp-470 polymer conjugates and use thereof |
| 01/12/2005 | EP1494651A2 Preservation of bioactive materials by freeze dried foam |
| 01/12/2005 | EP1494542A1 Composition for modulating a physiological reaction or inducing an immune response |
| 01/12/2005 | EP1459760A9 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 01/12/2005 | EP1183228B1 Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds. |
| 01/12/2005 | EP1077711B1 Treatment of papilloma virus infection using a mycobacterium |
| 01/12/2005 | EP1019026B1 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 01/12/2005 | EP0996460B1 Treatment of kidney fibrosis with antibodies against integrin alpha-v-beta 6 |
| 01/12/2005 | EP0750513B1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 01/12/2005 | EP0710251B1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 01/12/2005 | EP0627923B1 Therapeutic domains of von willebrand factor |
| 01/12/2005 | CN1564829A Antibodies to insulin-like growth factor I receptor |
| 01/12/2005 | CN1564826A Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 01/12/2005 | CN1563384A Recombined expression plamid vector, expression antige of N gene of bubble cell stomatitis virus and preparation method |
| 01/12/2005 | CN1563383A Plamid vector, VP7 expresses antigen of blue tongue virus VP7 gene recombined expression, and preparation method |
| 01/12/2005 | CN1563382A Gene of Chinese Mainland SJPP gene stock of japanese blood fluke, clone, expression and application |
| 01/12/2005 | CN1563092A Recombining single chained three specific antibodies of anti CCA, anti CD 3, anti CD 28 through genetic engineering |
| 01/12/2005 | CN1563088A Specific composite IgY for anti influenza and preparation |
| 01/12/2005 | CN1562371A Bilogical product of anti-corrosion agent containing merthiolate in ultralow density |
| 01/12/2005 | CN1562368A Oral cavity spraying agent for anticarious and preparation method |
| 01/12/2005 | CN1562367A Mucous membrane immunizing agent of polyglycol-inactivated vaccine |
| 01/12/2005 | CN1562366A SARS nucleic acid vaccine and preparation method, application of S gene in coronavirus |
| 01/12/2005 | CN1562365A SARS vaccine of adenovirus carrier and preparation method, application of coronavirus S gene |
| 01/12/2005 | CN1562364A Influenza vaccine sucked or sprayed through nasal cavity, preparation method |
| 01/12/2005 | CN1562363A Polypeptide vaccine of free from adjuvant for anti human chorionic gonadotrophin and preparation method |
| 01/12/2005 | CN1562362A Mosaic type DNA vaccine in use for preventing tuberculosis and immunological therapy |
| 01/12/2005 | CN1562361A Compound pefusion for anti bladder cancer |
| 01/12/2005 | CN1562354A Method for controlling mammal to give birth of female mammal based on H-Y antigen |
| 01/12/2005 | CN1562349A Bacterin of nucleic acid for anti atherosclerosis and preparation method |
| 01/12/2005 | CN1184320C Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/12/2005 | CN1184319C Chemosynthesized SARS virus S gene segement, its expression and application |
| 01/12/2005 | CN1184315C Death domain containing receptor 5 |
| 01/12/2005 | CN1184235C Chimeric polypeptides, method for production and uses thereof |
| 01/12/2005 | CN1183968C Improved vacines |
| 01/12/2005 | CN1183928C Chinese medicinal powder for resisting thrombosis and its preparation method |
| 01/11/2005 | US6841657 Inhibitors of HIV membrane fusion |
| 01/11/2005 | US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/11/2005 | US6841543 Contacting a human immune cell with a sufficient amount of a pharmaceutical composition consisting essentially of non-crosslinked, monovalent Lewisx antigen consisting of LNFP-III lacto-N-fucopentaose III |
| 01/11/2005 | US6841381 Immunization by inoculation of DNA transcription unit |
| 01/11/2005 | US6841374 Deactivated viral particle for preparing vaccine to prevent flaviviral infection |
| 01/11/2005 | US6841373 Preparing replication defective viral vector for gene transfer tool; genetic engineering |
| 01/11/2005 | US6841364 Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
| 01/11/2005 | US6841345 Reducing lymphadenopathy associated viral replication in monocytes; viricides |
| 01/11/2005 | US6841168 Method for the preservation of biologically-active material |
| 01/11/2005 | US6841160 Ability of IL-12 to increase the immune response to alum-based pneumococcal vaccines |
| 01/11/2005 | US6841158 Chicken embryo lethal orphan or fowl adenovirus type 1 genome contains a deletion consisting essentially of nucleotides 41,731-43,684 of the wild type |
| 01/11/2005 | US6841156 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion; relieving pain associated with smooth muscle disorders, including spasms in the sphincter muscles; type A & B toxins |
| 01/11/2005 | US6841155 Immunization against and treatment for infection by H. pylori |
| 01/11/2005 | US6841154 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and Staphylococcus aureus |
| 01/11/2005 | CA2169631C A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 01/11/2005 | CA2033175C Self-assembled, defective, non-self-propagating viral particles |
| 01/08/2005 | CA2469089A1 En-2 gene, disgnostic and therapeutic uses thereof |
| 01/07/2005 | CA2434995A1 Oncolytic viruses for the treatment of neoplasms having activated pp2a or rac |
| 01/06/2005 | WO2005001117A1 Method of selecting wt1 vaccine adaptive patient |
| 01/06/2005 | WO2005001103A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | WO2005001096A1 Vaccines against sars |
| 01/06/2005 | WO2005001092A2 Compositions and methods for diagnosing and treating cancers |
| 01/06/2005 | WO2005001069A1 Genetic marker for live bacterial vaccines |
| 01/06/2005 | WO2005001059A2 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 01/06/2005 | WO2005001053A2 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist |
| 01/06/2005 | WO2005001052A2 Modulation of apoptosis |
| 01/06/2005 | WO2005001040A2 Non-lethal conditioning methods for conditioning a recipient for bone marrow transplantation |
| 01/06/2005 | WO2005001038A2 Recombinant anti-cd30 antibodies and uses thereof |
| 01/06/2005 | WO2005001033A2 Tolerance induction and maintenance in hematopoietic stem cell allografts |
| 01/06/2005 | WO2005001029A2 Ancestral viruses and vaccines |
| 01/06/2005 | WO2005001025A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/06/2005 | WO2005000900A1 Treatment with anti-vegf antibodies |
| 01/06/2005 | WO2005000899A2 Modified binding molecules comprising connecting peptides |
| 01/06/2005 | WO2005000898A2 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 01/06/2005 | WO2005000891A2 Thrombopoietin proteins with improved properties |
| 01/06/2005 | WO2005000889A1 Immunogenic peptides for the treatment of prostate and breast cancer |
| 01/06/2005 | WO2005000886A2 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 01/06/2005 | WO2005000884A1 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 01/06/2005 | WO2005000881A2 Live attenuated viral vaccines for eastern equine encephalitis virus |
| 01/06/2005 | WO2005000871A2 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 01/06/2005 | WO2005000351A2 Combination therapy for b cell disorders |
| 01/06/2005 | WO2005000348A2 Vaccines inducing nkt-cell and toll-like-receptor activation |
| 01/06/2005 | WO2005000347A1 Vaccines against group y neisseria meningitidis and meningococcal combinations thereof |
| 01/06/2005 | WO2005000346A1 Carrier proteins for vaccines |